George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Pin to quick picksPVG.L Regulatory News (PVG)

  • There is currently no data for PVG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Blocklisting Six Monthly Return

2 Jun 2015 17:10

RNS Number : 0061P
Premier Veterinary Group PLC
02 June 2015
 



 

Premier Veterinary Group plc

 

2 June 2015

 

BLOCKLISTING SIX MONTHLY RETURN

 

 

1. Name of applicant

Premier Veterinary Group plc (formerly known as Ark Therapeutics Group plc)

2. Name of scheme

Ark Therapeutics Group Unapproved Share Option Scheme

3. Period of return

From 03/12/2014 - 02/06/2015

4. Balance of unallotted securities under scheme from previous return

2,271,252

5. Plus: The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return (if any increase has been applied for)

Nil

6. Less: Number of securities issued/allotted under the scheme during period

Nil

7. Equals: Balance under the scheme not yet issued/allotted at end of period

2,271,252

 

NOTES:

 

· The number of shares stated represent the position prior to the share reorganisation which took effect on 13/12/2015.

 

· There are no options outstanding under this plan which has now expired. The block listing is, therefore, now closed.

 

 

BLOCKLISTING SIX MONTHLY RETURN

 

1. Name of applicant

Premier Veterinary Group plc (formerly known as Ark Therapeutics Group plc)

2. Name of scheme

Ark Therapeutics Group Enterprise Management Incentive Share Option Plan

3. Period of return

From 03/12/2014 - 02/06/2015

4. Balance of unallotted securities under scheme from previous return

939,433

5. Plus: The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return (if any increase has been applied for)

Nil

6. Less: Number of securities issued/allotted under the scheme during period

Nil

7. Equals: Balance under the scheme not yet issued/allotted at end of period

939,433

 

NOTES:

 

· The number of shares stated represent the position prior to the share reorganisation which took effect on 13/12/2015.

 

· There are no options outstanding under this plan which has now expired. The block listing is, therefore, now closed.

 

 

BLOCKLISTING SIX MONTHLY RETURN

 

1. Name of applicant

Premier Veterinary Group plc (formerly known as Ark Therapeutics Group plc)

2. Name of scheme

Ark Therapeutics Group 2005 Long Term Incentive Plan

3. Period of return

From 03/12/2014 - 02/06/2015

4. Balance of unallotted securities under scheme from previous return

683,200

5. Plus: The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return (if any increase has been applied for)

Nil

6. Less: Number of securities issued/allotted under the scheme during period

Nil

7. Equals: Balance under the scheme not yet issued/allotted at end of period

683,200

 

NOTES:

 

· The number of shares stated represent the position prior to the share reorganisation which took effect on 13/12/2015.

 

· There are no awards outstanding under this plan which has now expired. The block listing is, therefore, now closed.

 

 

BLOCKLISTING SIX MONTHLY RETURN

 

1. Name of applicant

Premier Veterinary Group plc (formerly known as Ark Therapeutics Group plc)

2. Name of scheme

Ark Therapeutics Group Approved Share Option Plan

3. Period of return

From 03/12/2014 - 02/06/2015

4. Balance of unallotted securities under scheme from previous return

1,000,000

5. Plus: The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return (if any increase has been applied for)

Nil

6. Less: Number of securities issued/allotted under the scheme during period

Nil

7. Equals: Balance under the scheme not yet issued/allotted at end of period

1,000,000

 

NOTES:

 

· The number of shares stated represent the position prior to the share reorganisation which took effect on 13/12/2015.

 

· There are no options outstanding under this plan which has now expired. The block listing is, therefore, now closed.

 

 

Name of contact:

Sue Steven, Company Secretary

Telephone number of contact:

+44(0)117 970 4127

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BLREAKKAEENSEFF
Date   Source Headline
6th Jun 20122:41 pmRNSBlocklisting Interim Review
18th May 201212:02 pmRNSHolding(s) in Company
18th May 201212:01 pmRNSDirector Dealings
18th May 201211:57 amRNSResult of AGM
17th May 20127:00 amRNSInterim Management Statement
16th May 20127:00 amRNSCompletion of Phase 1 Study
2nd May 20127:00 amRNSGrant and Patent Update
25th Apr 20127:00 amRNSRegulatory Approval of Manufacturing Suite
17th Apr 20122:36 pmRNSDirector/PDMR Shareholding
10th Apr 20127:00 amRNSNew Board Appointment
2nd Apr 20123:25 pmRNSAnnual Information Update
26th Mar 20127:00 amRNSChange of Broker Name
15th Mar 20124:09 pmRNSDirector/PDMR Shareholding
13th Mar 20124:16 pmRNSBoard Changes
12th Mar 20127:00 amRNSFinal Results
23rd Feb 20124:29 pmRNSHolding(s) in Company
9th Feb 201211:10 amRNSNotice of Results
8th Feb 20127:00 amRNSUS patent for Neuropilin-1 receptor
4th Jan 20127:00 amRNSManufacturing Update
7th Dec 201111:48 amRNSDirector/PDMR Shareholding
5th Dec 20112:35 pmRNSBlocklisting Interim Review
9th Nov 20117:00 amRNSInterim Management Statement
3rd Nov 20117:00 amRNSManufacturing agreement
16th Sep 20114:41 pmRNSSecond Price Monitoring Extn
16th Sep 20114:35 pmRNSPrice Monitoring Extension
12th Sep 20117:00 amRNSRe Agreement
24th Aug 20115:29 pmRNSHalf Yearly Report on National Storage Mechanism
24th Aug 20117:00 amRNSHalf Yearly Report - Part 2
24th Aug 20117:00 amRNSHalf Yearly Report - Part 1
1st Aug 20114:31 pmRNSHolding(s) in Company
29th Jul 20114:40 pmRNSSecond Price Monitoring Extn
29th Jul 20114:35 pmRNSPrice Monitoring Extension
25th Jul 20114:40 pmRNSSecond Price Monitoring Extn
25th Jul 20114:35 pmRNSPrice Monitoring Extension
18th Jul 20113:10 pmRNSHolding(s) in Company
14th Jul 20117:00 amRNSWins ?5.3 million EU Framework Programme 7 Grant
6th Jul 20117:00 amRNSArk receives Finnish Grants
4th Jul 20117:00 amRNSGrant of US patents and milestone payments
13th Jun 20114:40 pmRNSSecond Price Monitoring Extn
13th Jun 20114:35 pmRNSPrice Monitoring Extension
3rd Jun 201111:57 amRNSBlocklisting Interim Review
17th May 20117:00 amRNSInterim Management Statement
9th May 20113:28 pmRNSAGM Results
31st Mar 20111:43 pmRNSAnnual Information Update
30th Mar 20111:08 pmRNSDirector/PDMR Shareholding
24th Mar 20113:40 pmRNSAnnual Financial Report
9th Mar 20117:00 amRNSFinal Results
3rd Mar 20117:00 amRNSAppointment of CFO
2nd Mar 20117:00 amRNSDisposal
28th Feb 201111:49 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.